NUS Stock Chart & Stats
$81.00
$0.00(0.00%)
At close: 4:00 PM EDT
$81.00
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$79.48 - $200.00
Previous CloseN/A
Volume0.00
Average Volume (3M)16.00
Market Cap
$4.01B
Enterprise Value$328.94
Total Cash (Recent Filing)$189.64M
Total Debt (Recent Filing)$263.74M
Price to Earnings (P/E)―
Beta0.75
Next Earnings
Nov 04, 2026EPS Estimate
3.58Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.45
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume16
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)0.59
Price to Sales (P/S)0.32
P/FCF Ratio10.31
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)17.06
Revenue Forecast (FY)$24.32B
Bulls Say, Bears Say
Bulls Say
Strong Core Gross MarginA strong core gross margin indicates attractive product economics and potential pricing power. Sustaining these margins can help Nu Skin absorb distribution, product-development, and restructuring costs while supporting future operating leverage.
Prysm IO Product AdoptionGrowing device placements and scan activity provide evidence of engagement with a differentiated wellness platform. The planned AI-enabled app could deepen personalization, improve affiliate conversion, and increase customer lifetime value over time.
Manageable Leverage And LiquidityModerate leverage and substantial cash provide financial flexibility while the company executes its operating transition. Positive operating cash flow supports ongoing investment and reduces immediate dependence on additional borrowing.
Bears Say
Persistent Revenue And Profitability DeclineA multi-year revenue contraction limits operating leverage and suggests challenges in customer retention, affiliate productivity, or market demand. The recent net loss further weakens internal funding capacity and raises execution risk.
Operating Margin And Cash Flow PressureLower operating margins and sharply reduced free cash flow indicate weaker cash conversion despite positive gross margins. If sustained, this could constrain product investment, restructuring efforts, dividends, and the company’s ability to rebuild growth.
Salesforce Execution And Expansion DelaysDirect selling depends heavily on recruiting, leadership development, and affiliate execution. Persistent capability gaps can slow Prysm iO adoption and regional growth, while the India delay postpones diversification and reduces near-term expansion potential.
Nu Skin News
NUS FAQ
What was Nu Skin Enterprises’s price range in the past 12 months?
Nu Skin Enterprises lowest stock price was $79.48 and its highest was $200.00 in the past 12 months.
What is Nu Skin Enterprises’s market cap?
Nu Skin Enterprises’s market cap is $4.01B.
When is Nu Skin Enterprises’s upcoming earnings report date?
Nu Skin Enterprises’s upcoming earnings report date is Nov 04, 2026 which is in 54 days.
How were Nu Skin Enterprises’s earnings last quarter?
Nu Skin Enterprises released its earnings results on Aug 10, 2026. The company reported $3.414 earnings per share for the quarter.
Is Nu Skin Enterprises overvalued?
According to Wall Street analysts Nu Skin Enterprises’s price is currently Overvalued.
Does Nu Skin Enterprises pay dividends?
Nu Skin Enterprises does not currently pay dividends.
What is Nu Skin Enterprises’s EPS estimate?
Nu Skin Enterprises’s EPS estimate is 3.58.
How many shares outstanding does Nu Skin Enterprises have?
Currently, no data Available
What happened to Nu Skin Enterprises’s price movement after its last earnings report?
Nu Skin Enterprises reported an EPS of $3.414 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Nu Skin Enterprises?
Currently, no hedge funds are holding shares in MX:NUS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nu Skin Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-56.11%
12-Months-Change
Fundamentals
Return on Equity
4.95%
Trailing 12-Months
Asset Growth
-22.32%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Nu Skin Enterprises
Nu Skin Enterprises, Inc. (NUS) is a global enterprise dedicated to the creation and worldwide distribution of beauty and wellness solutions. The company's diverse product offerings encompass advanced skincare systems, such as the ageLOC Spa and ageLOC Transformation age-defying lines, innovative devices like the ageLOC LumiSpa for comprehensive skin treatment and cleansing, and the ageLOC Boost, alongside various other cosmetic and personal care items. In the realm of health and nutrition, Nu Skin provides a comprehensive array of dietary and weight management products. This includes ageLOC Youth, LifePak, and ageLOC Meta nutritional supplements, in addition to ageLOC TR90 programs designed for weight control and body contouring, Beauty Focus Collagen+ skin care supplements, and other related weight management aids. The organization also significantly invests in research and development, particularly for its skincare and nutritional supplement portfolios. Nu Skin operates a network of retail stores and customer service centers exclusively within Mainland China. Its extensive product lines are marketed under its proprietary brands, which include Nu Skin, Pharmanex, and ageLOC. These products reach consumers through multiple sales channels, including direct-to-consumer interactions, an extensive network of independent distributors, and its dedicated e-commerce platform. Nu Skin Enterprises, Inc. was established in 1984 and maintains its corporate headquarters in Provo, Utah.
NUS Company Deck
NUS Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mixed picture: strong product momentum and engagement around Prysm iO, improved core gross margin, cost reductions in G&A, and disciplined liquidity position are notable positives. However, sizable non-cash goodwill and deferred tax charges materially impacted reported earnings, adjusted operating margins declined, recruiting and leadership development remain weak, and the India launch was delayed. Near-term FX headwinds and modest operating cash flow further temper the outlook. On balance, the company shows encouraging strategic traction and product adoption but faces meaningful near-term financial and operational headwinds.View all MX:NUS earnings summaries